American Oncology Network Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15	39	96	93	92
Market Cap Growth	10044.56%	-58.83%	3.08%	1.56%	-
Enterprise Value	37	139	196	129	92
PE Ratio	-	-7.12	37.00	-885.15	4.17
PS Ratio	0.01	0.03	0.08	0.10	0.13
PB Ratio	-0.41	-0.24	-6.74	-4451.70	-109724.94
P/FCF Ratio	1.10	-1.30	-6.85	-2.68	3.66
P/OCF Ratio	0.57	-2.18	-14.12	-3.53	2.46
EV/Sales Ratio	0.03	0.11	0.17	0.14	0.13
EV/EBITDA Ratio	-3.75	533.45	8.49	16.46	3.53
EV/EBIT Ratio	-2.24	-8.45	32.63	72.88	4.11
EV/FCF Ratio	2.96	-4.58	-14.02	-3.73	3.66
Debt / Equity Ratio	-1.25	-0.79	-8.95	-3050.84	0
Debt / EBITDA Ratio	-5.01	491.67	5.51	8.11	-
Debt / FCF Ratio	10.18	-4.22	-9.10	-1.84	-
Quick Ratio	1.17	1.35	1.44	1.39	0
Current Ratio	1.39	1.64	1.72	1.75	0
Asset Turnover	18.39	3.42	3.52	3.80	75714.90
Interest Coverage	-10.91	-7.66	1.63	0.64	19.78
Return on Equity (ROE)	12.89%	3.43%	-18.23%	502.93%	-2632014.39%
Return on Assets (ROA)	-3.13%	-1.48%	0.79%	-0.04%	229325.11%
Return on Capital (ROIC)	-250.00%	147.16%	-1949.61%	-0.42%	-2744417.12%
Earnings Yield	-95.12%	-14.05%	2.70%	-0.11%	23.99%
FCF Yield	90.98%	-77.07%	-14.59%	-37.29%	27.35%
Buyback Yield / Dilution	-17976.75%	29.87%	-	-	-
Total Shareholder Return	-17976.75%	29.87%	-	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.